Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
MLTX
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -70.6%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
moonlake
immunotherapeutics
securities
class
action
lawsuit
investors
about
fraud
drug
firm
deadline
sonelokimab
phase
against
trial
results
misleading
after
lead
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
StonvexStonvexStonvexStonvex